down arrow

Kinnate Biopharma, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals: Major
  • ISIN: US49705R1059
USD
2.65
0.00 (0.00%)

Apr 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.000.00

52 Week

1.054.50
Valuation
Technical
Day's Volume

CASH

0

Shareholding (Dec 2023)

FII

15.89%

Held by 43 FIIs

DII

11.13%

Held by 18 DIIs

Promoter

60.29%

How big is Kinnate Biopharma, Inc.?

22-Jun-2025

As of Apr 04, Kinnate Biopharma, Inc. has a market capitalization of 124.99 million and reported net sales of 0.00 million with a net profit of -112.65 million over the last four quarters.

Market Cap: As of Apr 04, Kinnate Biopharma, Inc. has a market capitalization of 124.99 million, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Kinnate Biopharma, Inc. reported net sales of 0.00 million and a net profit of -112.65 million.<BR><BR>Balance Sheet Snapshot: As of Dec'23, the company's shareholder's funds amounted to 159.33 million, while total assets were reported at 173.60 million.

Read More

What does Kinnate Biopharma, Inc. do?

22-Jun-2025

Kinnate Biopharma, Inc. is a micro-cap pharmaceutical company with a recent net profit loss of $17 million and a market cap of $124.99 million. It has no dividends, a negative P/E ratio, and a return on equity of -69.34%.

Overview:<BR>Kinnate Biopharma, Inc. operates in the pharmaceuticals industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Profit: -17 Million (Quarterly Results - Dec 2023)<BR>Market cap: USD 124.99 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making)<BR>Industry P/E: NA<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.96<BR>Return on Equity: -69.34%<BR>Price to Book: 0.78<BR><BR>Contact Details:<BR>Details: No Company Details Available<BR>Registrar Address: Not available.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals: Major

stock-summary
Market cap

USD 125 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.96

stock-summary
Return on Equity

-69.34%

stock-summary
Price to Book

0.78

Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2023)
Net Profit:
-17 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.43%
0%
6.43%
6 Months
107.03%
0%
107.03%
1 Year
-57.94%
0%
-57.94%
2 Years
-75.84%
0%
-75.84%
3 Years
-91.48%
0%
-91.48%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Kinnate Biopharma, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-226.76%
EBIT to Interest (avg)
-89.28
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.78
EV to EBIT
0.24
EV to EBITDA
0.24
EV to Capital Employed
-4.55
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-69.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 28 Schemes (12.69%)

Foreign Institutions

Held by 43 Foreign Institutions (15.89%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Sep 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 44.30% vs 3.76% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.90",
          "val2": "-30.90",
          "chgp": "38.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-2.00",
          "chgp": "90.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-17.10",
          "val2": "-30.70",
          "chgp": "44.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 3.18% vs -29.51% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-118.20",
          "val2": "-126.00",
          "chgp": "6.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-112.60",
          "val2": "-116.30",
          "chgp": "3.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQstock-summary
Dec'23
Sep'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-18.90
-30.90
38.83%
Interest
0.00
0.00
Exceptional Items
-0.20
-2.00
90.00%
Consolidate Net Profit
-17.10
-30.70
44.30%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Dec 2023 is 0.00% vs 0.00% in Sep 2023

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2023 is 44.30% vs 3.76% in Sep 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-118.20
-126.00
6.19%
Interest
0.00
0.00
Exceptional Items
-2.20
0.00
Consolidate Net Profit
-112.60
-116.30
3.18%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 3.18% vs -29.51% in Dec 2022

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kinnate Biopharma, Inc. stock-summary
stock-summary
Kinnate Biopharma, Inc.
Pharmaceuticals: Major
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."